Skip to main content
Top
Published in: Current Cardiovascular Imaging Reports 3/2011

01-06-2011

Improving Efficiency in the Nuclear Cardiology Laboratory: The Role of Stress-Only Imaging Coupled with Faster Acquisition Protocols and New Stressor Agents

Author: John J. Mahmarian

Published in: Current Cardiovascular Imaging Reports | Issue 3/2011

Login to get access

Abstract

Laboratory efficiency is an important benchmark to achieve whether imaging is hospital-based or in the private practice setting. The stressor and imaging protocols used and the camera systems available for imaging all play a pivotal role toward this end. A same-day low-dose rest/high-dose stress imaging protocol has been widely adopted in nuclear cardiology laboratories. However, recent studies indicate that rest imaging may be unnecessary in patients with a normal initial stress single photon emission CT (SPECT) study. Appropriate elimination of rest imaging would decrease costs, streamline patient evaluations, and significantly reduce radiation exposure. Several recent studies have validated the safety of stress-only imaging in patients who have an initially normal perfusion study. Combined with new pharmacologic stressor agents and camera systems that can complete imaging within minutes, laboratory efficiency and patient satisfaction should improve considerably. The following article will review these currently available advances in SPECT imaging.
Literature
1.
go back to reference Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.PubMedCrossRef Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003;42:1318–33.PubMedCrossRef
2.
go back to reference Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–85.PubMedCrossRef Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–85.PubMedCrossRef
3.
go back to reference Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94:33D–40.PubMedCrossRef Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004;94:33D–40.PubMedCrossRef
4.
go back to reference Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.PubMedCrossRef Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.PubMedCrossRef
5.
go back to reference Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14:514–20.PubMedCrossRef Lieu HD, Shryock JC, von Mering GO, et al. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans. J Nucl Cardiol. 2007;14:514–20.PubMedCrossRef
6.
go back to reference Udelson JE, Heller GV, Wackers FJ, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation. 2004;109:457–64.PubMedCrossRef Udelson JE, Heller GV, Wackers FJ, et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation. 2004;109:457–64.PubMedCrossRef
7.
go back to reference Udelson JE, Iteld BJ, Weiland FL, et al. Double-blinded comparison of the side effects associated with pharmacologic stress induced with binodenoson and adenosine (abstr). J Nucl Cardiol. 2008;15:S17–8.CrossRef Udelson JE, Iteld BJ, Weiland FL, et al. Double-blinded comparison of the side effects associated with pharmacologic stress induced with binodenoson and adenosine (abstr). J Nucl Cardiol. 2008;15:S17–8.CrossRef
8.
go back to reference •• Cerqueira MD, Nguyen P, Staehr P, et al.: Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008, 1:307–316. The ADVANCE-MPI were two pivotal trials which demonstrated the non-inferiority of regadenoson as compared to adenosine myocardial perfusion imaging. These two trials led to FDA approval of regadenoson as a pharmacologic stressor agent. PubMedCrossRef •• Cerqueira MD, Nguyen P, Staehr P, et al.: Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008, 1:307–316. The ADVANCE-MPI were two pivotal trials which demonstrated the non-inferiority of regadenoson as compared to adenosine myocardial perfusion imaging. These two trials led to FDA approval of regadenoson as a pharmacologic stressor agent. PubMedCrossRef
9.
go back to reference • Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al.: Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2009, 2:959–968. This substudy of the ADVANCE-MPI 2 trial used quantitative polar plot analysis to demonstrate that regadenoson induces total and ischemic perfusion defects of comparable size as adenosine. These results infer that regadenoson perfusion results should result in comparable diagnostic and prognostic information as that obtained with adenosine stress. PubMedCrossRef • Mahmarian JJ, Cerqueira MD, Iskandrian AE, et al.: Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging 2009, 2:959–968. This substudy of the ADVANCE-MPI 2 trial used quantitative polar plot analysis to demonstrate that regadenoson induces total and ischemic perfusion defects of comparable size as adenosine. These results infer that regadenoson perfusion results should result in comparable diagnostic and prognostic information as that obtained with adenosine stress. PubMedCrossRef
10.
go back to reference Murray JJ, Weiler JM, Schwartz LB, et al. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circ Cardiovasc Imaging. 2009;2:492–8.PubMedCrossRef Murray JJ, Weiler JM, Schwartz LB, et al. Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma. Circ Cardiovasc Imaging. 2009;2:492–8.PubMedCrossRef
11.
go back to reference Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15:319–28.PubMedCrossRef Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial (RegCOPD trial). J Nucl Cardiol. 2008;15:319–28.PubMedCrossRef
12.
go back to reference Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15:329–36.PubMedCrossRef Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. J Nucl Cardiol. 2008;15:329–36.PubMedCrossRef
13.
go back to reference Aljaroudi W, Hermann D, Hage F, et al. Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol. 2010;105:133–5.PubMedCrossRef Aljaroudi W, Hermann D, Hage F, et al. Safety of regadenoson in patients with end-stage renal disease. Am J Cardiol. 2010;105:133–5.PubMedCrossRef
14.
go back to reference Gaemperli O, Schepis T, Koepfli P, et al. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol. 2008;51:328–9.PubMedCrossRef Gaemperli O, Schepis T, Koepfli P, et al. Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography: a randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol. 2008;51:328–9.PubMedCrossRef
15.
go back to reference Hansen CL, Goldstein RA, Akinboboye OO, et al. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007;14:e39–60.PubMedCrossRef Hansen CL, Goldstein RA, Akinboboye OO, et al. Myocardial perfusion and function: single photon emission computed tomography. J Nucl Cardiol. 2007;14:e39–60.PubMedCrossRef
16.
go back to reference Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80–90.PubMedCrossRef Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al. Stress protocols and tracers. J Nucl Cardiol. 2006;13:e80–90.PubMedCrossRef
17.
go back to reference Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99 m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69–77.PubMedCrossRef Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99 m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69–77.PubMedCrossRef
18.
go back to reference Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures (editorial). J Nucl Cardiol. 2006;13:19–23.PubMedCrossRef Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures (editorial). J Nucl Cardiol. 2006;13:19–23.PubMedCrossRef
19.
go back to reference Laskey WK, Feinendegen LE, Neumann RD, Dilsizian V. Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging. 2010;3:517–24.PubMedCrossRef Laskey WK, Feinendegen LE, Neumann RD, Dilsizian V. Low-level ionizing radiation from noninvasive cardiac imaging: can we extrapolate estimated risks from epidemiologic data to the clinical setting? JACC Cardiovasc Imaging. 2010;3:517–24.PubMedCrossRef
20.
go back to reference DesPrez RD, Dahlberg ST, Einstein AJ, et al.: Stress-only myocardial perfusion imaging. 2009 clinical update. Available at http://www.asnc.org. Accessed March 2010 DesPrez RD, Dahlberg ST, Einstein AJ, et al.: Stress-only myocardial perfusion imaging. 2009 clinical update. Available at http://​www.​asnc.​org. Accessed March 2010
21.
go back to reference Gibson PB, Demus D, Noto R, et al. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol. 2002;39:999–1004.PubMedCrossRef Gibson PB, Demus D, Noto R, et al. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol. 2002;39:999–1004.PubMedCrossRef
22.
go back to reference Gal R, Ahmad M. Cost-saving approach to normal technetium-99 m sestamibi myocardial perfusion scan. Am J Cardiol. 1996;78:1047–9.PubMedCrossRef Gal R, Ahmad M. Cost-saving approach to normal technetium-99 m sestamibi myocardial perfusion scan. Am J Cardiol. 1996;78:1047–9.PubMedCrossRef
23.
go back to reference Bateman TM, Heller GV, McGhie AI, et al. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99 m SPECT imaging. J Nucl Cardiol. 2009;16:726–35.PubMedCrossRef Bateman TM, Heller GV, McGhie AI, et al. Multicenter investigation comparing a highly efficient half-time stress-only attenuation correction approach against standard rest-stress Tc-99 m SPECT imaging. J Nucl Cardiol. 2009;16:726–35.PubMedCrossRef
24.
go back to reference • Duvall WL, Wijetunga MN, Klein TM, et al.: The prognosis of a normal stress-only Tc-99 m myocardial perfusion imaging study. J Nucl Cardiol 2010, 17:370–377. This study demonstrated the feasibility of stress-only imaging and that a normal stress-only study predicts the same low risk as a standard rest-stress study. PubMedCrossRef • Duvall WL, Wijetunga MN, Klein TM, et al.: The prognosis of a normal stress-only Tc-99 m myocardial perfusion imaging study. J Nucl Cardiol 2010, 17:370–377. This study demonstrated the feasibility of stress-only imaging and that a normal stress-only study predicts the same low risk as a standard rest-stress study. PubMedCrossRef
25.
go back to reference •• Chang SM, Nabi F, Xu J, et al.: Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010, 55:221–230. This is a 16,000-patient study demonstrating the safety of a normal stress-only versus a normal stress-rest myocardial perfusion study, with similar patient outcomes irrespective of the imaging protocol or patient profile. This study demonstrated a 61% lower radiopharmaceutical dosage with stress-only versus conventional stress-rest imaging. PubMedCrossRef •• Chang SM, Nabi F, Xu J, et al.: Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 2010, 55:221–230. This is a 16,000-patient study demonstrating the safety of a normal stress-only versus a normal stress-rest myocardial perfusion study, with similar patient outcomes irrespective of the imaging protocol or patient profile. This study demonstrated a 61% lower radiopharmaceutical dosage with stress-only versus conventional stress-rest imaging. PubMedCrossRef
26.
go back to reference Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–33.PubMedCrossRef
27.
go back to reference Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–40.PubMedCrossRef
28.
go back to reference Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551–61.PubMedCrossRef Navare SM, Mather JF, Shaw LJ, Fowler MS, Heller GV. Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551–61.PubMedCrossRef
29.
go back to reference Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137(2 Suppl):S68–97.CrossRef Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res. 1994;137(2 Suppl):S68–97.CrossRef
30.
go back to reference Radiation dose to patients from radiopharmaceuticals. (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997. Ann ICRP. 1998;28:1–126. Radiation dose to patients from radiopharmaceuticals. (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997. Ann ICRP. 1998;28:1–126.
32.
go back to reference Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872–82.PubMedCrossRef Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol. 2009;54:1872–82.PubMedCrossRef
33.
go back to reference • Maddahi J, Mendez R, Mahmarian JJ, et al.: Prospective multicenter evaluation of rapid, gated SPECT myocardial perfusion upright imaging. J Nucl Cardiol 2009, 16:351–357. This was one of the first studies to address the feasibility and comparable image quality of half-time versus full-time imaging. PubMedCrossRef • Maddahi J, Mendez R, Mahmarian JJ, et al.: Prospective multicenter evaluation of rapid, gated SPECT myocardial perfusion upright imaging. J Nucl Cardiol 2009, 16:351–357. This was one of the first studies to address the feasibility and comparable image quality of half-time versus full-time imaging. PubMedCrossRef
34.
go back to reference • Venero CV, Heller GV, Bateman TM, et al.: A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction. J Nucl Cardiol 2009, 16:714–725. This study demonstrated comparable image quality with half-time imaging using concomitant iterative reconstruction as compared to standard filtered back projection. PubMedCrossRef • Venero CV, Heller GV, Bateman TM, et al.: A multicenter evaluation of a new post-processing method with depth-dependent collimator resolution applied to full-time and half-time acquisitions without and with simultaneously acquired attenuation correction. J Nucl Cardiol 2009, 16:714–725. This study demonstrated comparable image quality with half-time imaging using concomitant iterative reconstruction as compared to standard filtered back projection. PubMedCrossRef
35.
go back to reference DePuey EG, Gadiraju R, Clark J, et al. Ordered subset expectation maximization and wide beam reconstruction “half-time” gated myocardial perfusion SPECT functional imaging: a comparison to “full-time” filtered backprojection. J Nucl Cardiol. 2008;15:547–63.PubMedCrossRef DePuey EG, Gadiraju R, Clark J, et al. Ordered subset expectation maximization and wide beam reconstruction “half-time” gated myocardial perfusion SPECT functional imaging: a comparison to “full-time” filtered backprojection. J Nucl Cardiol. 2008;15:547–63.PubMedCrossRef
36.
go back to reference Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255–76.PubMedCrossRef Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255–76.PubMedCrossRef
37.
go back to reference • Sharir T, Slomka PJ, Hayes SW, et al.: Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol 2010, 55:1965–1974. Using the novel D-SPECT rapid imaging system, comparable quantitative total and ischemic perfusion defect sizes were obtained as seen with conventional imaging. PubMedCrossRef • Sharir T, Slomka PJ, Hayes SW, et al.: Multicenter trial of high-speed versus conventional single-photon emission computed tomography imaging: quantitative results of myocardial perfusion and left ventricular function. J Am Coll Cardiol 2010, 55:1965–1974. Using the novel D-SPECT rapid imaging system, comparable quantitative total and ischemic perfusion defect sizes were obtained as seen with conventional imaging. PubMedCrossRef
38.
go back to reference Garcia EV, Tsukerman L, Keidar Z. A new solid state, ultra fast cardiac multi-detector SPECT system (abstr). J Nucl Cardiol. 2008;15:S3.CrossRef Garcia EV, Tsukerman L, Keidar Z. A new solid state, ultra fast cardiac multi-detector SPECT system (abstr). J Nucl Cardiol. 2008;15:S3.CrossRef
39.
go back to reference Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol. 2009;16:927–34.PubMedCrossRef Esteves FP, Raggi P, Folks RD, et al. Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol. 2009;16:927–34.PubMedCrossRef
Metadata
Title
Improving Efficiency in the Nuclear Cardiology Laboratory: The Role of Stress-Only Imaging Coupled with Faster Acquisition Protocols and New Stressor Agents
Author
John J. Mahmarian
Publication date
01-06-2011
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 3/2011
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-011-9084-6

Other articles of this Issue 3/2011

Current Cardiovascular Imaging Reports 3/2011 Go to the issue